| lidocaine 5% / Generic mfg. |
NCT00989040: Impact of Neuropathic Post-Zosterian Pain on the Cognition |
|
|
| Completed | N/A | 100 | Europe | usual treatment: Versatis | University Hospital, Clermont-Ferrand | Neuropathic Post-zosterian Pain, Cognition | 06/09 | 09/09 | | |
NCT03120351: Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery |
|
|
| Completed | N/A | 80 | US | Lidoderm 5 % Topical Patch, Lidoderm, Placebo patch | The Cleveland Clinic, Endo Pharmaceuticals | Perioperative Chest Pain | 04/11 | 04/11 | | |
NCT02751619: Preventive Skin Analgesia With Lidocaine Patch 5% for Controlling Post-thoracotomy Pain |
|
|
| Completed | N/A | 90 | Europe | Lidocaine patch 5%, Lidoderm® (Endo Pharmaceuticals Inc, Malvern, PA, USA), Placebo patch | University of Campania "Luigi Vanvitelli" | Pain, Postoperative | 05/15 | 12/15 | | |
NCT02749123: Comparison of Prescription Lidocaine Patch to Over the Counter Lidocaine Patch and Placebo for Back Pain and Arthritis |
|
|
| Unknown status | N/A | 100 | US | lidocaine 5% patch, Lidoderm, lidocaine 3.6%, menthol 1.25%, LidoPatch, Placebo | J.A.R. Laboratories | Back Pain, Arthritis | 05/16 | 05/16 | | |
NCT00659633: The Effect of Intravenous Lidocaine on Allodynia |
|
|
| Completed | N/A | 10 | US | lidocaine, Lidoderm, Xylocaine | University of Alabama at Birmingham, American Society of Regional Anesthesia | Pain | 06/16 | 08/16 | | |
NCT04322760: Lidocaine 5% Patch Supplementation to Intra-articular Bupivacaine Dexmedetomidine After Arthroscopic Knee Surgery |
|
|
| Completed | N/A | 40 | NA | Lidocaine 5% patch with Dexmedetomidine Bupivacaine, Dexmedetomidine Bupivacaine | Tanta University | Dexmedetomidine, Lidocaine 5% Patch, Arthroscopic Knee Surgery, Intra-articular | 11/17 | 12/17 | | |
| Withdrawn | N/A | 0 | NA | TDS Lidocaine 5%; generic, TDS Lidocaine 5%; RLD | SRI International, TKL Research, Inc. | Skin Manifestations | 12/17 | 12/17 | | |
NCT06312254: Pharmacological Modulation of Peripheral Nerve Excitability |
|
|
| Not yet recruiting | N/A | 20 | Europe | Topical lidocaine 5%, Topical Phenytoin 10%, Topical Mepyramine 2%, Topical Placebo | Aalborg University | Peripheral Neuropathy | 02/25 | 08/25 | | |
